Powerful chemo cocktail aims to wipe out rectal cancer before surgery
NCT ID NCT03997435
First seen Nov 17, 2025 · Last updated May 16, 2026 · Updated 22 times
Summary
This study tests whether adding a stronger chemotherapy regimen (FOLFOXIRI) to standard chemoradiation before surgery can improve outcomes for people with high-risk locally advanced rectal cancer. About 72 participants will be randomly assigned to receive either standard treatment or the intensified combination. The main goal is to see if the cancer completely disappears by the time of surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Clinical Oncology, Queen Mary Hospital
Hong Kong, Hong Kong
-
Department of Oncology, Princess Margaret Hospital
Hong Kong, Hong Kong
-
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.